Sponsored By


Lung function at birth
may predict asthma.


Drug reactions
cause 700,000
ED visits a year.

 
  
Oct. 25, 2006
  
Welcome to ACAAI eNews — a bi-weekly aggregated news service from the American College of Allergy, Asthma & Immunology. To be removed from this distribution list, please see instructions at bottom.
 
Top Stories
 
Distance Learning
   
Drugs and Devices
   
Association News
   
Fellows-in-Training
   
Calendar
   
Archive
FIT Archive
Members:
update 
e-mail address
here
  
Non-members:
subscribe here

 

ACAAI Home
 

Distance Learning
2005 Board/Recertification Review Course:
DVDs, Audio CDs, MP3s
Link

ACAAI Tape Store
Complete Listing
Link

2005 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 4-9, Anaheim
Link

2004 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 12-17, Boston
Link

2003 ACAAI ANNUAL MEETING
Nov. 7-12, 2003, New Orleans
• Two Symposia Online
Link

• Plenary Sessions CD-ROM and DVD
Link

Patient-Centered Allergy Practice
Endorsed by ACAAI, Sponsored by Physicians Practice
Link

 
Calendar

NOVEMBER
ACAAI XII International Food Allergy Symposium
Nov. 9, Philadelphia
ACAAI Annual Meeting
Nov. 9-15, Philadelphia
Tel: 847-427-1200
E-mail
Link

DECEMBER
International Congress on Exacerbations of Airway Disease
Dec. 8-10, San Juan, Puerto Rico
Tel: 212-988-7732
E-mail
Link

ONGOING
World Allergy Organization Society Meetings

ACAAI CME Website
Contact: Mary Campbell
Tel: 847-427-1200
E-mail

 Sponsored By

 
  
Top Stories
 
At-birth lung function may be asthma predictor
Infants who perform poorly on lung function tests at birth may be more likely to develop asthma before they are 10 years old, according to a study in the New England Journal of Medicine. Scientists at Ulleval University Hospital in Oslo, Norway, enrolled 616 10-year-olds who had received lung-function tests at birth. All were full-term infants who appeared healthy. Each subject was evaluated for asthma via lung function tests, blood samples and allergy testing. Parents reported that 20 percent of the children had a history of asthma and 11 percent currently had asthma. Among the children with poorer lung function tests at birth, more than 24 percent had a history of asthma. Among the children who had normal lung function at birth, about 16 percent had a history of asthma. Of the subjects currently with asthma, 7.5 percent had normal lung function tests at birth, vs. 14.6 percent who had poorer lung function tests.

One-third of in-hospital asthma deaths among exacerbation admissions
Up to one-third of all asthma deaths happen in patients hospitalized for asthma exacerbations, according to a study in the American Journal of Respiratory and Critical Care Medicine. Scientists at the University of Chicago analyzed 65,381 hospital admissions for asthma exacerbation in patients over 5 years old. The in-hospital asthma death rate was 0.5 percent. Of 4,487 deaths from asthma, 33 percent occurred in patients hospitalized for asthma exacerbations. Researchers saw no significant race differences in asthma exacerbation hospital deaths.

Adverse drug reactions cause of 700,000 ED visits per year
Approximately 700,000 Americans per year have adverse reactions to prescription drugs that require emergency department visits, according to a study in the Journal of the American Medical Association. Researchers at the Centers for Disease Control and Prevention in Atlanta evaluated 21,298 adverse drug event cases that were reported to a national surveillance system, from Jan. 1, 2004, to Dec. 31, 2005. These results yielded weighted annual estimates of 701,547 persons treated in emergency departments for adverse drug reactions. Adverse drug events included allergic reactions, unintended overdoses, adverse effects, secondary effects, and vaccine reactions.
 
A message from President Dr. William Dolen

Kudos to Dr. John Yarbrough of Gainesville, Ga., who told me last year how the iPod and video iPod would revolutionize CME. I had never heard of podcasting, but right after that I learned that the Medical College of Georgia is planning to put most of our lectures in the iPod's mp4 format over the next several years. I was still skeptical until I actually saw a video iPod. The screen resolution on the video device is absolutely amazing, and skepticism quickly turned into lust. Imagine going to a meeting, hearing a lecture, and having the slides (with audio) automatically (or on demand) download to your computer to review at your leisure. We have the technology.

Please be patient with us as we work out the fine points of podcasting a live medical meeting. For years, we've been badgering speakers to produce legible slides, yet every year we still have some idiot (sorry if I'm talking about you) who will put 40 lines of light blue text on a dark blue background and expect the audience to read along. On the screen at a national meeting, it's difficult. On the iPod — it will be absolutely illegible. Ten lines of text, and no more, please. There could also be audio glitches at the beginning. We will want your feedback, as well as your ideas for other opportunities for podcasting.

Profound thanks to the fine folks at GlaxoSmithKline who have provided an educational grant to support production of this initial series of podcasts. Supporting innovative distance learning is going out on a limb in a big way, and we appreciate their help.

(Disclosure: although your President has been a rabid Macintosh user since 1984, he has no relationship with Apple Computer, Inc.)

Best wishes,
Bill
 
Drugs and Devices
 
Proventil to transition to HFA propellant
Schering-Plough Corporation will begin Nov. 1 to transition from its chlorofluorocarbon-containing albuterol asthma inhalers distributed by its Warrick Pharmaceuticals division to Proventil® HFA (albuterol sulfate), an albuterol inhaler that delivers the same medicine with an environmentally friendly propellant, hydrofluoroalkane. The company is complying with the Montreal Protocol and its requirement to remove ozone-depleting substances. Warrick Pharmaceuticals plans to cease manufacturing CFC inhalers in early 2007.

FDA approves ciclesonide nasal spray
The U.S. Food and Drug Administration recently approved of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with allergic rhinitis in adults and children, 12 years and older. Omnaris is a corticosteroid. The drug’s most common side effects in clinical studies were headache, nosebleeds, and inflammation of the nose and throat linings. Omnaris is manufactured by ALTANA Pharma US Inc. of Florham Park, N.J.
 
Association News
 

Final Program for the ACAAI Annual Meeting now online
Plan your itinerary for the Nov. 9-15 ACAAI Annual Meeting using the complete Final Program now available online.

Scan the scientific program for up-to-date sessions and speakers. Select the workshops and Meet the Professor Breakfasts tailored to your needs. Note which concurrent sessions and poster presentations you don’t want to miss. Jot down the social events in your calendar and make those last-minute tour reservations.

Order your tickets today for the Sunday evening, Nov. 12, Annual Fundraising Dinner with Peter Nero and the Philly Pops.

Online registration is closed, but it’s not too late to register in advance so your package will be ready to pick-up at Registration. Downloadable Meeting Registration Forms also are online for faxing.

For more information, contact ACAAI by e-mail: meetings@acaai.org, by telephone: (847) 427-1200, or fax: (847) 427-1294.

Symposium impacted by extended release
of new asthma guidelines

An extended release date for the new NAEPP Asthma Guidelines has resulted in changes in the Sunday, Nov. 12, 3:30 to 5:30 p.m. symposium.

“Like everyone else, I was looking forward to a first look at the long-awaited update to the NAEPP Asthma Guidelines," says Dr. Jay Portnoy, chair of the Pharmaceutical Symposium Committee. “Though the symposium won’t have specific information from the new guidelines, it will have a stellar faculty to discuss issues related to the use and implementation of Guidelines and to discuss what they anticipate the new document will, and won’t, address. This should lead to a fascinating preview of what is to come.”

The featured symposium, “Controversial Issues Involving Asthma Disease Management: Implications for Asthma Guidelines,” moderated by Dr. Michael B. Foggs, will include the following presentations:

What the Guidelines Didn’t Say
— Dr. Thomas A.E. Platts-Mills

Controversies in Beta-agonist Therapy: Implications for Evidence-Based — Asthma Guidelines Dr. John Oppenheimer

Implementing Asthma Guidelines Emphasizing Evidence-Based Parameters — Dr. Sheldon L. Spector

Upon completion of this session, participants should be able to: 1) describe the limits of the guidelines; 2) recognize the importance of variability of response to treatment of asthma; 3) evaluate the role of allergies in asthma; 4) implement practical aspects of guidelines; and 5) discuss concepts from guidelines.

Win a free 30 GB Video iPod at the ACAAI Annual Meeting
Doctors and allied health professionals who register for the Annual Meeting will be given a raffle ticket in their registration packets for a chance to win one of 10 30 GB video iPods. The ticket must be deposited into a collection box in the Exhibit Hall to qualify for the drawing and participants must be present to win.

The drawings will be held 10:20 a.m., 12:20 p.m., and 3:20 p.m. on Monday in the back of Exhibit Hall D. Three iPod winners will be drawn during each of the two breaks, and four at lunch time.

Annual Meeting programs will be available as video podcasts
The College announces a new initiative to electronically deliver scientific presentations from this year’s Annual Meeting directly to its members as Vodcasts (video podcasts) beginning in November.

Bi-weekly, members can view or download 30-minute Vodcasts of key sessions to their computers or portable media players. Users can retrieve files manually from the College Web site or subscribe at no cost to a feed that automatically downloads Vodcasts each time a new presentation is posted.

The first Vodcasts will contain the slides and audio from this year’s Food Allergy Symposium and Literature Review Course. Other key scientific sessions and non-meeting related material also will be broadcast throughout the year.

Watch for more information about this new and exciting service sponsored by an education grant from GlaxoSmithKline.

Online registration now open for the Board Review Course
Register online for the ACAAI/AAAAI Certification/Maintenance of Certification Board Review Course, April 19-22, 2007, at the Renaissance Hotel in Chicago.

The Allergy and Immunology Review Course 2007 is developed and presented by a conjoint committee appointed by ACAAI and AAAAI. As ABAI is the certifying organization for the specialty — and separate from these educational organizations — ABAI Directors responsible for preparing the 2007 ABAI examinations are not involved with the course presentations. Content outlines for the examination are available on the ABAI Web site.

The Conjoint Planning Committee includes Drs. Emil J. Bardana Jr. (co-chair), Dennis Ledford (co-chair), Thomas A. Fleisher, David A. Khan, Phillip Lieberman, Kathleen R. May, Dennis R. Ownby, and William T. Shearer.

Board Review Course programs have been mailed to all College and AAAAI members.

Look for your copy of the flu vaccination pocket guide
The 2006-07 Influenza Vaccination Pocket Information Guide has been mailed with your copy of ACAAI News.

The handy quick reference card includes the following:
• Indications
• Contraindications and precautions
• Vaccine dosing and administration
• Side effects
• Talking points with patients

The Immunization Action Coalition (www.immunize.org) created the cards in collaboration with the National Influenza Vaccine Summit.

Patient information “Flu Vaccine and Egg Allergy” online
New patient education information about “Flu Vaccine and Egg Allergy,” developed by the College’s Public Education Committee and the Drugs and Anaphylaxis Committee, is available online.

“Patients with egg allergy should understand the risks associated with some flu vaccines,” said Dr. A. M. Aminian, Public Education Committee chair. “They also should be informed that allergists have expertise to administer the vaccine even for some people with egg allergy, which is especially important for those with respiratory or age-related risk factors attributed to complications caused by influenza.”

 
Fellows-in-Training
 

Immunology Review Corner
Welcome to the Board Review Corner prepared by Karla R. Davis, M.D., Senior Representative of ACAAI’s fellows-in-training (FITs) to the Board of Regents. The Board Review Corner is your chance to test your Board preparedness.

To refer to a previous Board Review Corner, click the “Archive” link in the left column.

Immunology Review Corner: Chapter 80 of the 6th edition of Middleton’s Allergy Principles and Practice, edited by N. Franklin Adkinson, et al. Review questions were written by Drs. Karla R. Davis, Landstuhl Regional Medical Center in Germany, and Soo Kim-Delio, Walter Reed Army Medical Center.


Copyright © 2006 American College of Allergy, Asthma & Immunology. All rights reserved.

E-newsletter services provided by the medical editors at Ascend Media, LLC.

Do you have news, responses or opinions to share with us? Please e-mail the association office at enews@acaai.org
  
THIS E-MAIL WAS SENT FROM A “SEND-ONLY” MAILBOX. Please DO NOT REPLY to this e-mail.
ACAAI eNews is sent as a membership benefit of the American College of Allergy, Asthma & Immunology. If you would prefer not to receive future issues and want to remove your name from our mailing list, please -click here-